Antituberculars/ranitidineErythroderma and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1951卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36842-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：65 / 65

相关论文

共 50 条

[31] ImmunosuppressantsHepatotoxicity and lack of efficacy: case report
Reactions Weekly, 2022, 1908 (1) : 287 - 287
[32] AntineoplasticsFatigue and lack of efficacy: case report
Reactions Weekly, 2023, 1984 (1) : 66 - 66
[33] OctreotideAsystole and lack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 512 - 512
[34] VismodegibFatigue and lack of efficacy: case report
Reactions Weekly, 2024, 2036 (1) : 461 - 461
[35] PlasmaHypernatraemia and lack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 432 - 432
[36] AntineoplasticsMyelosuppression and lack of efficacy: case report
Reactions Weekly, 2021, 1849 (1) : 51 - 51
[37] AntineoplasticsPseudocirrhosis and lack of efficacy: case report
Reactions Weekly, 2021, 1885 (1) : 75 - 75
[38] DurvalumabColitis and lack of efficacy: case report
Reactions Weekly, 2025, 2056 (1) : 181 - 181
[39] AntineoplasticsNeutropenia and lack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 89 - 89
[40] DurvalumabPneumonitis and lack of efficacy: case report
Reactions Weekly, 2023, 1985 (1) : 208 - 208

← 1 2 3 4 5 →